ID28811A - Antagonis reseptor vitronektin - Google Patents

Antagonis reseptor vitronektin

Info

Publication number: ID28811A
Authority: ID; Indonesia
Prior art keywords: vitronektin; receptor antagonists; antagonists; receptor; vitronektin receptor
Prior art date: 1998-12-04

Application number

IDW00200101183A

Other languages

English (en)

Inventor

William H Miller

Peter J Manley

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-04

Filing date

1999-12-03

Publication date

2001-07-05

1999-12-03 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-07-05 Publication of ID28811A publication Critical patent/ID28811A/id

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Hematology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)

IDW00200101183A 1998-12-04 1999-12-03 Antagonis reseptor vitronektin ID28811A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11090398P	1998-12-04	1998-12-04

Publications (1)

Publication Number	Publication Date
ID28811A true ID28811A (id)	2001-07-05

Family

ID=22335565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101183A ID28811A (id)	1998-12-04	1999-12-03	Antagonis reseptor vitronektin

Country Status (39)

Country	Link
US (1)	US6495560B1 (id)
EP (1)	EP1146874B1 (id)
JP (1)	JP4481504B2 (id)
KR (1)	KR100620485B1 (id)
CN (1)	CN1147300C (id)
AP (1)	AP1534A (id)
AR (1)	AR035006A1 (id)
AT (1)	ATE277043T1 (id)
AU (1)	AU754408B2 (id)
BG (1)	BG65118B1 (id)
BR (1)	BR9915879A (id)
CA (1)	CA2353415A1 (id)
CO (1)	CO5150166A1 (id)
CZ (1)	CZ20011963A3 (id)
DE (1)	DE69920518T2 (id)
DK (1)	DK1146874T3 (id)
DZ (1)	DZ2954A1 (id)
EA (1)	EA003254B1 (id)
EG (1)	EG24025A (id)
ES (1)	ES2229798T3 (id)
HK (1)	HK1042037B (id)
HU (1)	HUP0104804A3 (id)
ID (1)	ID28811A (id)
IL (2)	IL143390A0 (id)
MA (1)	MA25265A1 (id)
NO (1)	NO318895B1 (id)
NZ (1)	NZ511876A (id)
OA (1)	OA11724A (id)
PE (1)	PE20001563A1 (id)
PL (1)	PL195973B1 (id)
PT (1)	PT1146874E (id)
SI (1)	SI1146874T1 (id)
SK (1)	SK7452001A3 (id)
TR (1)	TR200101654T2 (id)
TW (1)	TW482673B (id)
UA (1)	UA71586C2 (id)
UY (1)	UY25824A1 (id)
WO (1)	WO2000033838A1 (id)
ZA (1)	ZA200104398B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004525069A (ja)	2000-06-15	2004-08-19	ファルマシア・コーポレーション	インテグリン受容体アンタゴニストとしてのシクロアルキルアルカン酸
ATE320258T1 (de) *	2000-10-24	2006-04-15	Merck & Co Inc	Dibenzoxazepin-alpha-v-integrin- rezeptorantagonist
ATE530183T1 (de)	2001-01-29	2011-11-15	Ortho Mcneil Pharm Inc	Substituierte indole und ihre verwendung als integrin-antagonisten
US6872730B2 (en) *	2001-04-27	2005-03-29	3-Dimensional Pharmaceuticals, Inc.	Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
US20040224986A1 (en)	2002-08-16	2004-11-11	Bart De Corte	Piperidinyl targeting compounds that selectively bind integrins
WO2004058760A1 (en)	2002-12-20	2004-07-15	Pharmacia Corporation	Thiazole compounds as integrin receptor antagonists derivatives
GB0319069D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Therapeutically useful compounds
WO2006069079A2 (en) *	2004-12-21	2006-06-29	Smithkline Beecham Corporation	Methods and formulations
JP5781159B2 (ja)	2010-07-14	2015-09-16	ノバルティスアーゲー	Ｉｐ受容体アゴニストヘテロ環式化合物
UY34572A (es)	2012-01-13	2013-09-02	Novartis Ag	Compuestos heterocíclicos agonistas del receptor ip
WO2014125413A1 (en)	2013-02-13	2014-08-21	Novartis Ag	Ip receptor agonist heterocyclic compounds
ES2957460T3 (es)	2013-09-24	2024-01-19	Fujifilm Corp	Composición farmacéutica de un compuesto que contiene nitrógeno o una sal del mismo, o complejo de metal de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2687154B1 (fr)	1992-02-07	1995-05-12	Rhone Poulenc Rorer Sa	Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
ES2197950T3 (es) *	1995-06-29	2004-01-16	Smithkline Beecham Corporation	Antagonistas del receptor de la integrina.
WO1998013278A1 (de) *	1996-09-27	1998-04-02	Merkler, H.	Tank für flüssigkeiten, insbesondere für chemisch aggressive flüssigkeiten
EP0946180A4 (en) *	1996-10-07	2003-07-23	Smithkline Beecham Corp	METHODS FOR STIMULATING BONE FORMATION
UY24949A1 (es)	1997-04-08	2001-04-30	Smithkline Beecham Corp	Compuestos calcilíticos

1999
- 1999-03-12 UA UA2001063754A patent/UA71586C2/uk unknown
- 1999-11-29 TW TW088120752A patent/TW482673B/zh not_active IP Right Cessation
- 1999-11-29 UY UY25824A patent/UY25824A1/es unknown
- 1999-11-30 PE PE1999001197A patent/PE20001563A1/es not_active Application Discontinuation
- 1999-11-30 CO CO99075061A patent/CO5150166A1/es unknown
- 1999-12-01 DZ DZ990254A patent/DZ2954A1/xx active
- 1999-12-02 EG EG154299A patent/EG24025A/xx active
- 1999-12-02 AR ARP990106128A patent/AR035006A1/es unknown
- 1999-12-03 PT PT99960647T patent/PT1146874E/pt unknown
- 1999-12-03 OA OA1200100139A patent/OA11724A/en unknown
- 1999-12-03 DK DK99960647T patent/DK1146874T3/da active
- 1999-12-03 CN CNB998159735A patent/CN1147300C/zh not_active Expired - Fee Related
- 1999-12-03 PL PL99348702A patent/PL195973B1/pl not_active IP Right Cessation
- 1999-12-03 SI SI9930700T patent/SI1146874T1/xx unknown
- 1999-12-03 WO PCT/US1999/028662 patent/WO2000033838A1/en active IP Right Grant
- 1999-12-03 AT AT99960647T patent/ATE277043T1/de not_active IP Right Cessation
- 1999-12-03 ID IDW00200101183A patent/ID28811A/id unknown
- 1999-12-03 NZ NZ511876A patent/NZ511876A/xx unknown
- 1999-12-03 US US09/857,316 patent/US6495560B1/en not_active Expired - Lifetime
- 1999-12-03 IL IL14339099A patent/IL143390A0/xx active IP Right Grant
- 1999-12-03 SK SK745-2001A patent/SK7452001A3/sk unknown
- 1999-12-03 TR TR2001/01654T patent/TR200101654T2/xx unknown
- 1999-12-03 JP JP2000586330A patent/JP4481504B2/ja not_active Expired - Fee Related
- 1999-12-03 AU AU17502/00A patent/AU754408B2/en not_active Ceased
- 1999-12-03 HU HU0104804A patent/HUP0104804A3/hu unknown
- 1999-12-03 KR KR1020017006937A patent/KR100620485B1/ko not_active IP Right Cessation
- 1999-12-03 EA EA200100618A patent/EA003254B1/ru not_active IP Right Cessation
- 1999-12-03 BR BR9915879-5A patent/BR9915879A/pt not_active Application Discontinuation
- 1999-12-03 CZ CZ20011963A patent/CZ20011963A3/cs unknown
- 1999-12-03 ES ES99960647T patent/ES2229798T3/es not_active Expired - Lifetime
- 1999-12-03 AP APAP/P/2001/002156A patent/AP1534A/en active
- 1999-12-03 DE DE69920518T patent/DE69920518T2/de not_active Expired - Lifetime
- 1999-12-03 CA CA002353415A patent/CA2353415A1/en not_active Abandoned
- 1999-12-03 EP EP99960647A patent/EP1146874B1/en not_active Expired - Lifetime
2001
- 2001-05-24 IL IL143390A patent/IL143390A/en not_active IP Right Cessation
- 2001-05-29 ZA ZA200104398A patent/ZA200104398B/en unknown
- 2001-06-01 MA MA26218A patent/MA25265A1/fr unknown
- 2001-06-01 NO NO20012732A patent/NO318895B1/no not_active IP Right Cessation
- 2001-06-26 BG BG105651A patent/BG65118B1/bg unknown
2002
- 2002-02-27 HK HK02101522.3A patent/HK1042037B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
SK7452001A3 (en)	2001-12-03
TR200101654T2 (tr)	2002-03-21
IL143390A (en)	2006-07-05
AU754408B2 (en)	2002-11-14
ATE277043T1 (de)	2004-10-15
KR100620485B1 (ko)	2006-09-13
HK1042037B (zh)	2005-07-29
UY25824A1 (es)	2001-07-31
DE69920518D1 (de)	2004-10-28
NZ511876A (en)	2004-02-27
HK1042037A1 (en)	2002-08-02
JP4481504B2 (ja)	2010-06-16
US6495560B1 (en)	2002-12-17
CZ20011963A3 (cs)	2001-11-14
CO5150166A1 (es)	2002-04-29
MA25265A1 (fr)	2001-10-01
EP1146874A1 (en)	2001-10-24
PL195973B1 (pl)	2007-11-30
BG65118B1 (bg)	2007-03-30
HUP0104804A3 (en)	2002-12-28
CN1147300C (zh)	2004-04-28
ES2229798T3 (es)	2005-04-16
WO2000033838A1 (en)	2000-06-15
EP1146874B1 (en)	2004-09-22
EP1146874A4 (en)	2002-06-05
PL348702A1 (en)	2002-06-03
NO318895B1 (no)	2005-05-18
PT1146874E (pt)	2005-02-28
DE69920518T2 (de)	2005-09-22
EA003254B1 (ru)	2003-02-27
AR035006A1 (es)	2004-04-14
ZA200104398B (en)	2002-05-29
JP2003523931A (ja)	2003-08-12
KR20010080669A (ko)	2001-08-22
CA2353415A1 (en)	2000-06-15
SI1146874T1 (en)	2005-04-30
PE20001563A1 (es)	2001-02-09
IL143390A0 (en)	2002-04-21
EG24025A (en)	2008-03-26
NO20012732D0 (no)	2001-06-01
CN1334730A (zh)	2002-02-06
OA11724A (en)	2005-01-26
EA200100618A1 (ru)	2001-12-24
NO20012732L (no)	2001-08-01
BR9915879A (pt)	2002-02-13
HUP0104804A2 (hu)	2002-05-29
AU1750200A (en)	2000-06-26
AP1534A (en)	2006-01-09
UA71586C2 (en)	2004-12-15
TW482673B (en)	2002-04-11
DK1146874T3 (da)	2005-01-31
DZ2954A1 (fr)	2004-06-20
BG105651A (en)	2002-02-28

Publication	Publication Date	Title
ID19623A (id)	1998-07-23	Antagonis reseptor vitronektin
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
ATE280157T1 (de)	2004-11-15	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20012411D0 (no)	2001-05-16	Pyrrolidin-derivater-CCR-3-reseptorantagonister
IS5706A (is)	2000-11-07	Adenosín A3 viðtakastillar
DK1009732T3 (da)	2003-09-22	1-Amino-alkylcyclohexan NMDA receptor antagonister
DE69905248T2 (de)	2004-01-29	Neuropeptid y5-rezeptorantagonisten
ID18003A (id)	1998-02-19	Antagonis muskarinik
ID16742A (id)	1997-11-06	Antagonis reseptor endotelin
NO993586D0 (no)	1999-07-22	K-8 reseptor antagonister
ID26223A (id)	2000-12-07	Antagonis reseptor vitronektin
DE69919171D1 (de)	2004-09-09	Muskarin-rezeptor antagonisten
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
NO20015779L (no)	2001-11-27	Bradykinin-reseptorantagonister
ID26665A (id)	2001-01-25	Antagonis vla-4
ID28811A (id)	2001-07-05	Antagonis reseptor vitronektin
ID22838A (id)	1999-12-09	Oksazolidina sebagai antagonis 5-ht2a
ATE381330T1 (de)	2008-01-15	Il-8 rezeptor-antagonisten
ID24468A (id)	2000-07-20	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID27845A (id)	2001-04-26	Turunan tetrahidrokuilina sebagai antagonis glisilina
TR199501389A2 (tr)	1996-07-21	Adesyon reseptörü antagonistleri (karsitlari).
DE69831413D1 (de)	2005-10-06	Il-8 rezeptor antagonisten
ID24309A (id)	2000-07-13	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
NO20010620D0 (no)	2001-02-06	Vitronektinreseptor-antagonister